Ming Cheah
Director/Miembro de la Junta en HotSpot Therapeutics, Inc. .
Origen de la red de primer grado Ming Cheah.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Yale University
497
| College/University | Other Consumer Services | 497 |
Stanford University School of Medicine
27
| College/University | Other Consumer Services | 27 |
Pivotal Bioventure Partners Investment Advisor LLC
 Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California.
17
| Subsidiary | Investment Managers | 17 |
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA.
14
| Holding Company | Biotechnology | 14 |
Avalyn Pharma, Inc.
 Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA.
13
| Holding Company | Pharmaceuticals: Major | 13 |
Goldman Sachs Asset Management LP (Private Equity)
 Goldman Sachs Asset Management LP (Private Equity) Investment ManagersFinance Goldman Sachs Asset Management LP (Private Equity) (Goldman Sachs Asset Management) is a private equity firm founded in 1990. The firm is headquartered in New York.
13
| Subsidiary | Investment Managers | 13 |
Plexium, Inc.
 Plexium, Inc. Pharmaceuticals: MajorHealth Technology Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA.
11
| Holding Company | Pharmaceuticals: Major | 11 |
Arkuda Therapeutics, Inc.
 Arkuda Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arkuda Therapeutics, Inc. engages in development of medicines to improve the lives of patients with neurological diseases. It leverages insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease. The company was founded by Gerhard Koenig and Duane Burnett in 2018 and is headquartered in Cambridge, MA.
11
| Holding Company | Pharmaceuticals: Major | 11 |
McKinsey & Company Holdings Ltd.
 McKinsey & Company Holdings Ltd. Financial ConglomeratesFinance Part of McKinsey & Co., Inc., McKinsey & Company Holdings Ltd. is a consulting firm that partners with leaders on strategy, innovating to net zero, leading with tech, and building capabilities for a sustainable, inclusive, growing future. The company is based in London, UK. The British company specializes in Consumer Packaged Goods and has conducted research, articles, and reports on the changes that matter most for the challenges and opportunities ahead. The company was founded in 2011 by Brian K. Stafford.
9
| Subsidiary | Financial Conglomerates | 9 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Ming Cheah a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Nan Fung Life Sciences
 Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong. | Investment Managers | Consultant / Advisor Chief Operating Officer Consultant / Advisor Consultant / Advisor Private Equity Investor Consultant / Advisor Director of Finance/CFO Private Equity Investor Chief Executive Officer Private Equity Investor | |
| Stanford University | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Masters Business Admin Masters Business Admin Doctorate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Consultant / Advisor Consultant / Advisor Consultant / Advisor Consultant / Advisor | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| GOLDMAN SACHS BDC, INC. | Investment Managers | Chief Executive Officer Chief Operating Officer Director of Finance/CFO Director of Finance/CFO | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Founder Consultant / Advisor Chief Operating Officer Private Equity Investor | |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| SPRUCE BIOSCIENCES, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| OTONOMY | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| The Johns Hopkins University | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal | |
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
Cajal Neuroscience, Inc.
 Cajal Neuroscience, Inc. BiotechnologyHealth Technology Cajal Neuroscience is a biotechnology company that focuses on discovering new treatments for neurodegeneration. The company is based in Seattle, WA and was founded by Ian Peikon. The company uses advanced technologies such as integrative human genetics, multi-omics, functional genomics, and microscopy to accelerate their target and drug discovery. | Biotechnology | Director/Board Member Director/Board Member Founder | |
Goldman Sachs Middle Market Lending Corp. II
 Goldman Sachs Middle Market Lending Corp. II Financial ConglomeratesFinance Part of The Goldman Sachs Group, Inc., Goldman Sachs Middle Market Lending Corp. II provides investment services. The company is based in New York, NY. The CEOs of the company are Alex Chi, David Miller. | Financial Conglomerates | Chief Executive Officer Chief Operating Officer Director of Finance/CFO | |
Goldman Sachs Private Middle Market Credit II LLC
 Goldman Sachs Private Middle Market Credit II LLC Financial ConglomeratesFinance Goldman Sachs Private Middle Market Credit II LLC is a development stage pooled investment fund, which engages in investment activities. Its objective is to generate current income and, to a lesser extent, capital appreciation primarily through direct originations of secured debt. The company was founded on December 20, 2018 and is headquartered in New York, NY. | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal Director of Finance/CFO | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member Founder | |
| Pivotal Bioventure Partners China Advisor (Beijing) Co. Ltd. | Investment Managers | Private Equity Investor Corporate Officer/Principal Founder | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Kallyope, Inc.
 Kallyope, Inc. Medical/Nursing ServicesHealth Services Kallyope, Inc. engages in developing drugs and consumer products. Its specialties include biotechnology, gut-brain axis, nutrition, and pharmaceuticals. The company was founded by Thomas P. Maniatis, Charles Zuker and Richard Axel in 2014 and is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree | |
| NKARTA, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
IlluminOss Medical, Inc.
 IlluminOss Medical, Inc. Medical SpecialtiesHealth Technology IlluminOss Medical, Inc. engages in the designing, developing, and marketing of orthopedic fracture repair products. The company was founded by Robert A. Rabiner and Arnold-Peter C. Weiss in 2007 and is headquartered in East Providence, RI. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | President Corporate Officer/Principal Corporate Officer/Principal | |
| University of Illinois | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Engrail Therapeutics, Inc.
 Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Cardeas Pharma Corp.
 Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Founder Director/Board Member | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| University of California, Los Angeles | College/University | Graduate Degree Undergraduate Degree | |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member | |
| Virginia Polytechnic Institute & State University | College/University | Undergraduate Degree Graduate Degree | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Director/Board Member Director/Board Member | |
Goldman Sachs Private Middle Market Credit LLC
 Goldman Sachs Private Middle Market Credit LLC Investment Trusts/Mutual FundsMiscellaneous Goldman Sachs Private Middle Market Credit LLC seeks investment opportunities in middle market companies located in the United States. The fund targets companies operating across a broad range of sectors. It provides financing for buyout capital requirements. It also acquires minority interests. | Investment Trusts/Mutual Funds | Chief Executive Officer Director of Finance/CFO | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
Lux Capital Group LLC
 Lux Capital Group LLC Investment ManagersFinance Lux Capital Group LLC (Lux Capita Group) is a venture capital firm founded in 2000 by Peter Hebert and Josh Wolfe. The firm is headquartered in New York with an additional office in Menlo Park, California. | Investment Managers | Private Equity Analyst Consultant / Advisor | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Ziarco Group Ltd.
 Ziarco Group Ltd. Pharmaceuticals: MajorHealth Technology Ziarco Group Ltd. operates as a clinical-stage biotechnology company that develops therapeutics targeting inflammatory skin diseases. The firm engages in development of novel treatments in dermatology. The company was incorporated on March 10, 2014 and is headquartered in Canterbury, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder Founder | |
abrdn, Inc.
 abrdn, Inc. Investment ManagersFinance abrdn, Inc. is SEC-registered investment advisor and mutual fund manager headquartered in Philadelphia, Pennsylvania. Founded in 1995, the firm was formerly known as Aberdeen Asset Management, Inc. and as Aberdeen Standard Investments, Inc. until it became abrdn, Inc. in 2022. They are a subsidiary of abrdn Holdings Ltd., ultimately held by abrdn Plc (LON: ABDN) in Great Britain. abrdn provides investment products and solutions to various clients across the world. | Investment Managers | Portfolio Manager-Equities Analyst-Equity | |
Veracyte SD, Inc.
 Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Harvard T.H. Chan School of Public Health | College/University | Consultant / Advisor Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 48 |
| Reino Unido | 3 |
| China | 2 |
Sectorial
| Health Technology | 26 |
| Finance | 12 |
| Consumer Services | 11 |
| Commercial Services | 3 |
| Health Services | 2 |
Operativa
| Director/Board Member | 538 |
| Corporate Officer/Principal | 185 |
| Independent Dir/Board Member | 102 |
| Private Equity Investor | 87 |
| Founder | 82 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Bruce Booth | 40 |
| Heather Elizabeth Preston | 34 |
| Dan Omstead | 33 |
| Michael Grey | 32 |
| Joey Mason | 31 |
| Pascale Witz | 31 |
| Karoly Nikolich | 30 |
| Henry Skinner | 29 |
| Ernesto Zedillo Ponce de León | 28 |
| Peter Bisgaard | 28 |
| Emmett Cunningham | 28 |
| Graziano Seghezzi | 26 |
| Peter Moldt | 25 |
| Fouad Azzam | 25 |
| Steven J. Chu | 25 |
- Bolsa de valores
- Insiders
- Ming Cheah
- Conexiones Empresas